You are here

LixiLan

Sanofi's diabetes drug hits trial targets, heads for final approval

BioPharma Dive

Mon, 06/13/16 - 11:27 am

FDA sets LixiLan decision date for Sanofi-Novo diabetes showdown; Eylea could outshine Bayer's sales forecasts, analyst predicts

Fierce Pharma

Mon, 02/22/16 - 06:08 pm

Sanofi's diabetes combo clears a clinical hurdle in a race with Novo Nordisk

Fierce Biotech

Wed, 07/29/15 - 09:51 pm

type 2 diabetes

Sanofi's LixiLan Progresses

Yahoo/Zacks.com

Fri, 01/17/14 - 08:37 am

The Future of Sanofi's Insulin Empire

Motley Fool

Fri, 07/19/13 - 10:17 am